Sign in
4

Changes in Ownership

Axsome Therapeutics, Inc. Filed Acc 0000950170-24-094967

Chief Operating Officer sold 47,739 shares at $84.26 ($4,022,488)

  • Chief Operating Officer acquired 47,739 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Jacobson Mark L. Chief Operating Officer 2024-08-09 Option exercise 10b5-1 +47,739 $4.04 $192,866 53,522 D
Jacobson Mark L. Chief Operating Officer 2024-08-09 Sale 10b5-1 −47,739 $84.26 $4,022,488 5,783 D
Derivatives
Jacobson Mark L. Chief Operating Officer 2024-08-09 Option exercise · Stock Option (Right to Buy) 10b5-1 −47,739 0 D
Open-market sales · 47,739 sh · avg $84.26 · $4,022,488
Loading xslF345X05/ownership.xml…